Abound Wealth Management Adma Biologics, Inc. Transaction History
Abound Wealth Management
- $354 Billion
- Q2 2025
A detailed history of Abound Wealth Management transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Abound Wealth Management holds 10 shares of ADMA stock, worth $185. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10
Previous 15
33.33%
Holding current value
$185
Previous $298,000
38.59%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ADMA
# of Institutions
391Shares Held
190MCall Options Held
2.53MPut Options Held
696K-
Black Rock Inc. New York, NY18.6MShares$347 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.8MShares$313 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.9MShares$239 Million0.05% of portfolio
-
State Street Corp Boston, MA11.4MShares$213 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.67MShares$105 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.65B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...